How do you identify hemolysis in a patient undergoing hemodialysis (HD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Identifying Hemolysis During Hemodialysis

Hemolysis during hemodialysis is identified through a combination of clinical symptoms (abdominal pain, malaise, headache), visual inspection of blood in the extracorporeal circuit (pink or red discoloration), and laboratory confirmation with elevated plasma hemoglobin (>3 g/L), elevated LDH, and decreased or unmeasurable haptoglobin.

Clinical Presentation and Immediate Recognition

Cardinal Symptoms

  • Abdominal pain (60% of cases), malaise, nausea, and headache are the most common presenting symptoms during acute intradialytic hemolysis 1
  • Hypertension develops in approximately 66% of patients experiencing hemolysis during dialysis 1
  • Severe cases may progress to intensive care unit admission (36% of cases) with potential mortality 1

Visual Inspection of the Circuit

  • Pink or red discoloration of the blood in the extracorporeal circuit or dialysate indicates hemolysis and should prompt immediate investigation 2
  • Inspect the arterial and venous blood lines for kinking, particularly at the dialyzer inlet port and just after the pump segment where severe kinking can occur 2
  • Check for mechanical obstruction or narrowing of apertures in the blood tubing through which blood is pumped 1

Laboratory Confirmation

Primary Diagnostic Tests

  • Plasma hemoglobin elevation (3-21 g/L in documented cases) is the most direct indicator of intravascular hemolysis 1, 2
  • Haptoglobin is the most sensitive marker—levels become unmeasurable or severely decreased (<0.09 g/L) during hemolysis 1, 3
  • Lactate dehydrogenase (LDH) markedly elevates (542-3,300 IU/L in hemolysis cases) 1, 2
  • Unconjugated bilirubin increases as a secondary marker 3, 4

Important Caveats

  • Hemolysis interference affects LDH and AST measurements even at undetectable hemolysis levels by visual inspection (plasma hemoglobin <0.5 g/L), potentially confounding interpretation 5
  • Potassium and total bilirubin show clinically meaningful variations only in moderately hemolyzed samples (hemoglobin >1 g/L) 5
  • Reticulocyte counts typically exceed 120×10⁹/L, except during the very early phase of acute hemolysis or with associated vitamin deficiency 3

Systematic Investigation Algorithm

Step 1: Immediate Assessment During Dialysis

  • Monitor for sudden onset of abdominal pain, malaise, headache, or hypertension during treatment 1
  • Visually inspect blood lines and dialysate for pink/red discoloration 2
  • Check extracorporeal circuit pressures—back pressure without alarm may indicate occluded tubing causing hemolysis 2

Step 2: Equipment Inspection

  • Examine blood tubing for kinking at the dialyzer inlet port and immediately after the pump segment 2
  • Verify proper fitting of blood lines—extra long pump segments with short remaining tubing can cause severe kinking 2
  • Check for narrowing of apertures in disposable hemodialysis blood tubing cartridge sets 1
  • Review dialyzer clotting and anticoagulation protocol 6

Step 3: Laboratory Confirmation

  • Draw plasma hemoglobin level immediately (target: identify levels >3 g/L) 1
  • Measure haptoglobin (expect unmeasurable or <0.09 g/L) 1
  • Check LDH (expect >542 IU/L) 1
  • Obtain unconjugated bilirubin 3

Step 4: Rule Out Other Causes

  • Review for chemical contamination, heat exposure, or mechanical trauma beyond kinked lines 1, 4
  • Exclude hemodialyzer blood leak by checking for blood in dialysate 6
  • Verify blood pump calibration and review extracorporeal pressures (particularly prepump arterial pressure <-200 mmHg) 6
  • Check dialysate temperature—overheating can cause hemolysis 1

Common Pitfalls to Avoid

  • Do not rely solely on visual inspection for hemolysis detection—routine determination of plasma free hemoglobin concentrations is recommended to avoid improper sample rejection 5
  • Do not dismiss mild symptoms—hemolysis can progress rapidly from malaise to severe illness requiring ICU admission 1
  • Do not overlook blood line kinking as a cause—this mechanical trauma produces visible hemolysis within 30 minutes in experimental models 2
  • Do not continue dialysis if hemolysis is suspected—immediately release any kinked lines and consider stopping treatment if symptoms persist 2

Specific Hemolysis Thresholds for Laboratory Interference

When interpreting labs in suspected hemolysis:

  • Hemoglobin <0.5 g/L: LD and AST already affected 5
  • Hemoglobin >1 g/L: Potassium and total bilirubin show clinically meaningful variations 5
  • Hemoglobin 2.5-4.5 g/L: ALT, cholesterol, GGT, and inorganic phosphate remain unaffected 5

References

Related Questions

Can hemolysis be visually identified in blood lines during hemodialysis in patients with End-Stage Renal Disease (ESRD)?
What is the diagnosis and management for a patient with normocytic anemia, elevated Lactate Dehydrogenase (LDH), and a high reticulocyte (retic) count?
An 8-year-old girl, with a height and weight in the 10th percentile, presents with severe eye pain, scleral icterus, hepatomegaly, fever, tachycardia, and hypotension, along with laboratory findings of decreased haptoglobin and hemoglobin, what is the most likely diagnosis given her symptoms and lab results?
What is the best medication for a patient with hemolytic anemia, characterized by severe anemia (Hb: 68), elevated reticulocytes (4%), low haptoglobin, and high lactate dehydrogenase (LDH), who developed fatigue, abdominal pain, and jaundice after 3 days of hospital admission?
What is the next step in managing a pescetarian patient with anemia, hemolysis, and symptoms of dizziness and fatigue, who is already taking iron supplements?
What is the diagnosis for an immunocompromised adult patient with a history of Human Immunodeficiency Virus (HIV) infection, a low Cluster of Differentiation 4 (CD4) count, multiple ring-enhancing lesions on Magnetic Resonance Imaging (MRI), a negative Cerebrospinal Fluid (CSF) toxoplasmosis test, but positive Immunoglobulin G (IgG) serum toxoplasmosis?
What are the treatment implications for a patient with metastatic colon cancer and elevated lactate dehydrogenase (LDH) undergoing chemotherapy?
What treatment options are available for a patient with relapsing-remitting Multiple Sclerosis (MS) when preferred and alternative disease-modifying therapies (DMTs) are not available?
Is a patient with leptospirosis, severe hypotension requiring norepinephrine, pulmonary hemorrhage, and impaired renal function (creatinine level of 1.5) an indication for dialysis?
Can Azathioprine be used to treat a patient with relapsing-remitting Multiple Sclerosis (MS) who has not responded to or has contraindications to preferred disease-modifying therapies (DMTs)?
What is the initial management for a patient presenting with isolated thrombocytopenia (low platelet count)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.